NHS National Framework for Edoxaban
NHS England
- Value
- £8,640,000
- Published
- 10 Nov 2026
- Deadline
- Not stated
- Procedure
- Open procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- UKC, United Kingdom
- Notice reference
- 106853-2026
Requirements summary
NHS England is planning an open-procedure framework agreement for edoxaban, a pharmaceutical product, under a single lot with an estimated value of GBP 7.2m net (GBP 8.64m gross). The planned contract runs from 1 January 2028 to 31 December 2028, with renewal options up to 31 December 2030. The notice is a pipeline notice inviting suppliers planning to introduce edoxaban, or with questions, to contact the MPSC New Market Developments Team.
Key requirements
- Framework agreement for edoxaban supply under Lot 1, with a planned start on 1 January 2028 and end on 31 December 2028
- Optional renewal to a maximum extent date of 31 December 2030
- Delivery across seven English regions (UKC, UKD, UKF, UKG, UKH, UKJ, UKK)
- Estimated value of GBP 7.2m net (GBP 8.64m gross), procured through an open procedure
- Suitable for small and medium-sized enterprises (SMEs)
- Suppliers planning to introduce edoxaban or with questions should contact the MPSC New Market Developments Team before the future notice date of 4 May 2027